Älvsjö, Sweden

Lars Frelin

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Tumba, SE (2009)
  • Alvsjo, SE (2011 - 2012)
  • Tullinge, SE (2016)
  • Älvsjö, SE (2013 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lars Frelin

Introduction

Lars Frelin is a notable inventor based in Älvsjö, Sweden, recognized for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, Frelin has made strides in developing innovative solutions that enhance immune responses to various antigens.

Latest Patents

Frelin's latest patents include groundbreaking work on chimeric hepatitis D virus antigens and hepatitis B virus pre S1 genes. These inventions focus on the use of chimeric genes and compositions that are instrumental in generating, enhancing, or improving immune responses to target antigens. Notably, some embodiments of these compositions incorporate chimeric genes encoding hepatitis D antigen (HDAg) protein, combined with self-cleavage 2A polypeptides and preS1 polypeptides. In certain instances, the self-cleavage polypeptide utilized is P2A.

Career Highlights

Throughout his career, Lars Frelin has worked with prominent companies in the biotechnology sector, including Chrontech Pharma AB and Tripep AB. His work in these organizations has contributed to advancements in vaccine development and immune response enhancement.

Collaborations

Frelin has collaborated with esteemed colleagues such as Matti Sällberg and Jonas Soderholm, further enriching his research and innovation endeavors.

Conclusion

Lars Frelin's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence vaccine development and immune response strategies, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…